PHXM

PHAXIAM Therapeutics S.A.

3.86 USD
+0.95 (+32.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PHAXIAM Therapeutics S.A. stock is down -16.45% since 30 days ago. The next earnings date is Sep 21, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 7 February’s closed higher than January.

About PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.